Published in
Elsevier, The Lancet Oncology, 1(21), p. 121-133, 2020
DOI: 10.1016/s1470-2045(19)30671-0
Links
Tools
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
Journal article published in 2020 by
Birgit Geoerger,
Hyoung Jin Kang,
Michal Yalon-Oren,
Lynley V. Marshall,
Catherine Vezina,
Alberto Pappo,
Theodore W. Laetsch,
Antonio S. Petrilli,
Martin Ebinger,
Jacek Toporski 
,
Julia Glade-Bender,
Wayne Nicholls,
Elizabeth Fox,
Steven G. DuBois,
Margaret E. Macy
and other authors.
,
Julia Glade-Bender,
Wayne Nicholls,
Elizabeth Fox,
Steven G. DuBois,
Margaret E. Macy
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 